Gene expression signatures for Ibrutinib resistance in Diffuse Large B-cell Lymphoma (ABC-DLBCL)

ABSTRACT: To understand the acquired resistance mechanism in DLBCL the cell lines (OCI-Ly1, Oci-Ly10 and HBL-1) were treated with Ibrutinib over time to generate resistant clone.

ORGANISM(S): Homo sapiens

PROVIDER: GSE138126 | GEO | 2019/11/01

REPOSITORIES: GEO